Related Experiment Video

Updated: May 4, 2026

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
07:54

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Published on: April 13, 2017

9.4K

Microglia: a cellular vehicle for CNS gene therapy

Harald Neumann1

  • 1Neural Regeneration Unit, Institute of Reconstructive Neurobiology, University of Bonn, and LIFE & BRAIN Center and Hertie Foundation, Bonn, Germany. hneuman1@uni-bonn.de

The Journal of Clinical Investigation
|November 3, 2006
PubMed

Insights

Genetically modified stem cells can cross the blood-brain barrier to treat metachromatic leukodystrophy (MLD). These cells deliver the arylsulfatase A (ARSA) enzyme, correcting the deficiency in the central nervous system.

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Metachromatic leukodystrophy (MLD) is a lysosomal storage disease resulting from arylsulfatase A (ARSA) deficiency.
  • Progressive demyelination and neurological deficits characterize MLD.
  • The blood-brain barrier poses a significant challenge for MLD therapies.

Discussion:

  • Hematopoietic precursor cells genetically modified to overexpress ARSA were transplanted into Arsa(-/-) mice.
  • These modified cells successfully migrated into the central nervous system (CNS).
  • Microglia acted as cellular carriers, delivering ARSA to other brain cells, effectively cross-correcting the deficiency.

Key Insights:

  • Genetically engineered hematopoietic stem cells can overcome the blood-brain barrier.
  • Microglia play a crucial role in delivering therapeutic enzymes within the CNS.
  • Hepatocyte-mediated ARSA delivery did not correct CNS deficiency, highlighting the importance of cellular trafficking.

Outlook:

  • This study presents a promising cell-based therapeutic strategy for MLD.
  • Further research may explore optimizing cell trafficking and enzyme delivery for CNS disorders.
  • This approach could potentially be adapted for other lysosomal storage diseases affecting the brain.

More Related Videos

Transplantation of Human Induced Pluripotent Stem Cell-Derived Microglia in Immunocompetent Mice Brain via Non-Invasive Transnasal Route05:35

Transplantation of Human Induced Pluripotent Stem Cell-Derived Microglia in Immunocompetent Mice Brain via Non-Invasive Transnasal Route

Published on: May 31, 2022

3.7K
Author Spotlight: In Vitro Co-Culture Model for Studying Microglia-Neuronal Interactions in Disease Conditions08:47

Author Spotlight: In Vitro Co-Culture Model for Studying Microglia-Neuronal Interactions in Disease Conditions

Published on: July 26, 2024

3.3K

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
22.1K
Glial Cells01:04

Glial Cells

Overview
75.2K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K